Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01014728 · ClinicalTrials.gov registry record · NA
Intraoperative Bleeding During Endoscopic Sinus Surgery
A NA study, sponsored by University of Chicago.
- Completed
- Registry status
- NA
- Development phase
- 33
- Enrollment target
NCT01014728 is a NA study that has completed, run by University of Chicago. The registered enrollment target is 33 participants.
The verdict
NCT01014728, a NA study, has completed, sponsored by University of Chicago.
- COMPLETED
- Registry status
- NA
- Development phase
- 33 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the blood loss during sinus surgery looking at two different types of anesthesia: either intravenous anesthesia with propofol or inhalational anesthesia with sevoflurane.
Interventions
- DRUG propofol
- DRUG sevoflurane
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2009-11 |
| Est. Completion | 2012-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01014728
The ClinicalTrials.gov registry entry for NCT01014728 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which propofol is the first listed.
NCT01014728 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01014728 about?
NCT01014728 is a clinical study titled "Intraoperative Bleeding During Endoscopic Sinus Surgery". The purpose of this study is to compare the blood loss during sinus surgery looking at two different types of anesthesia: either intravenous anesthesia with propofol or inhalational anesthesia with sevoflurane.
What is the current status of trial NCT01014728?
This trial is currently completed. It is a NA study. The enrollment target is 33 participants. The study started on 2009-11. Estimated completion is 2012-06.
What interventions are being tested in trial NCT01014728?
The interventions under investigation include: propofol (DRUG), sevoflurane (DRUG).
Who is sponsoring clinical trial NCT01014728?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.